Your browser doesn't support javascript.
loading
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
Morrison, Anthony P; Pyle, Melissa; Gumley, Andrew; Schwannauer, Matthias; Turkington, Douglas; MacLennan, Graeme; Norrie, John; Hudson, Jemma; Bowe, Samantha E; French, Paul; Byrne, Rory; Syrett, Suzy; Dudley, Robert; McLeod, Hamish J; Griffiths, Helen; Barnes, Thomas R E; Davies, Linda; Kingdon, David.
Afiliação
  • Morrison AP; Psychosis Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK; Zochonis Building, University of Manchester, Manchester, UK; Division of Psychology and Mental Health, Zochonis Building, University of Manchester, Manchester, UK. Electronic address: tony.morrison@manche
  • Pyle M; Psychosis Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK; Zochonis Building, University of Manchester, Manchester, UK; Division of Psychology and Mental Health, Zochonis Building, University of Manchester, Manchester, UK.
  • Gumley A; Institute of Health and Wellbeing, University of Glasgow, Gartnavel Royal Hospital, Glasgow, UK.
  • Schwannauer M; Department of Clinical Psychology, School of Health in Social Science, Old Medical School, The University of Edinburgh, Edinburgh, UK.
  • Turkington D; Academic Psychiatry, Northumberland, Tyne and Wear NHS Foundation Trust, Centre for Aging and Vitality, Newcastle General Hospital, Newcastle upon Tyne, UK.
  • MacLennan G; Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
  • Norrie J; Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences & Informatics, Nine Edinburgh BioQuarter, The University of Edinburgh, Edinburgh, UK.
  • Hudson J; Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
  • Bowe SE; Psychosis Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK; Zochonis Building, University of Manchester, Manchester, UK.
  • French P; Psychosis Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK; Zochonis Building, University of Manchester, Manchester, UK; Institute of Psychology, Health and Society, University of Liverpool, Liverpool, UK.
  • Byrne R; Psychosis Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK; Zochonis Building, University of Manchester, Manchester, UK; Division of Psychology and Mental Health, Zochonis Building, University of Manchester, Manchester, UK.
  • Syrett S; Institute of Health and Wellbeing, University of Glasgow, Gartnavel Royal Hospital, Glasgow, UK.
  • Dudley R; School of Psychology, Newcastle University, Newcastle Upon Tyne, UK; Early Intervention in Psychosis Service, Northumberland, Tyne and Wear NHS Foundation Trust, Tranwell Unit, Queen Elizabeth Hospital, Gateshead, UK.
  • McLeod HJ; Institute of Health and Wellbeing, University of Glasgow, Gartnavel Royal Hospital, Glasgow, UK.
  • Griffiths H; Department of Clinical Psychology, School of Health in Social Science, Old Medical School, The University of Edinburgh, Edinburgh, UK.
  • Barnes TRE; The Centre for Psychiatry, Imperial College London, London, UK.
  • Davies L; Division of Population Health, Zochonis Building, University of Manchester, Manchester, UK.
  • Kingdon D; University Department of Psychiatry, Academic Centre, University of Southampton, Southampton, UK.
Lancet Psychiatry ; 5(8): 633-643, 2018 08.
Article em En | MEDLINE | ID: mdl-30001930

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Resistência a Medicamentos / Terapia Cognitivo-Comportamental / Clozapina Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Resistência a Medicamentos / Terapia Cognitivo-Comportamental / Clozapina Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article